The same active substances on other registers, the same brand first.
| Pack | Code | Status |
|---|---|---|
| HYDROXYPROGESTERONE CAPROATE 250MG/ML | ANDA089331-001 | Discontinued |
| HYDROXYPROGESTERONE CAPROATE 125MG/ML | ANDA089330-001 | Discontinued |
| HYDROXYPROGESTERONE CAPROATE 125MG/ML | NDA017439-001 | Discontinued |
| HYDROXYPROGESTERONE CAPROATE 250MG/ML | NDA017439-002 | Discontinued |
| HYDROXYPROGESTERONE CAPROATE 125MG/ML | NDA018004-001 | Discontinued |
The official texts, at the regulator.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Compiled by Prognia from the public register below; the register’s text is the official one.
Source: U.S. Food and Drug Administration, Drugs@FDA and openFDA drug labels (imported 10 June 2026). Not endorsed by the FDA.
Licence: Public domain (U.S. Government work); openFDA terms · Added 10 Jun 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
